Maiquer Group (002719.SZ) issued a forecast of a net loss for the year 2024, with an expected loss between 150 million to 220 million yuan.
Maiqul (002719.SZ) released its 2024 annual performance forecast, expecting a full-year attributable to shareholders of the listed company...
Maiquer Group (002719.SZ) has released its 2024 annual performance forecast, expecting a net loss attributable to the company's shareholders of 150 million to 220 million yuan for the full year. During the reporting period, increased competition in the dairy industry led to a decrease in the company's dairy product revenue. In response to intense market competition, the company continued to increase product promotions for its dairy business, resulting in a further decrease in operating profit, ultimately leading to a year-on-year decline in sales revenue and gross profit margin.
Related Articles
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
Jiangsu Hengrui Pharmaceuticals (600276.SH): some drugs have obtained approval letters for clinical trials of drugs.
CSPC Pharma (01093) cancelled 25.45 million repurchased shares on May 9th.
On May 9, the Minerva Group (00397) spent approximately HK$287,800 to repurchase 4.3 million shares.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
